The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) closed at $9.8 up 5.15% from its previous closing price of $9.32. In other words, the price has increased by $5.15 from its previous closing price. On the day, 2.22 million shares were traded. AVAH stock price reached its highest trading level at $9.82 during the session, while it also had its lowest trading level at $9.35.
Ratios:
For a deeper understanding of Aveanna Healthcare Holdings Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.22. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.09.
On August 19, 2025, UBS Upgraded its rating to Neutral which previously was Sell but kept the price unchanged to $8.
Barclays Upgraded its Equal Weight to Overweight on August 19, 2025, while the target price for the stock was maintained at $9.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 13 ’25 when Cunningham Patrick A. sold 18,500 shares for $4.93 per share. The transaction valued at 91,174 led to the insider holds 327,869 shares of the business.
J.H. Whitney Equity Partners V sold 750,000 shares of AVAH for $3,900,000 on Jun 10 ’25. The 10% Owner now owns 28,890,756 shares after completing the transaction at $5.20 per share. On Jun 10 ’25, another insider, VIGANO PAUL R, who serves as the 10% Owner of the company, sold 750,000 shares for $5.20 each. As a result, the insider received 3,900,000 and left with 28,890,756 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVAH now has a Market Capitalization of 2047184384 and an Enterprise Value of 3437694464. As of this moment, Aveanna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 130.32, and their Forward P/E ratio for the next fiscal year is 19.47. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.94. Its current Enterprise Value per Revenue stands at 1.579 whereas that against EBITDA is 14.807.
Stock Price History:
The Beta on a monthly basis for AVAH is 2.04, which has changed by 0.71955717 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, AVAH has reached a high of $9.35, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is 22.60%, while the 200-Day Moving Average is calculated to be 75.88%.
Shares Statistics:
For the past three months, AVAH has traded an average of 1.33M shares per day and 1287820 over the past ten days. A total of 208.26M shares are outstanding, with a floating share count of 45.17M. Insiders hold about 78.37% of the company’s shares, while institutions hold 23.52% stake in the company. Shares short for AVAH as of 1759190400 were 6193832 with a Short Ratio of 4.65, compared to 1756425600 on 4465272. Therefore, it implies a Short% of Shares Outstanding of 6193832 and a Short% of Float of 9.04.
Earnings Estimates
Currently, 9.0 analysts are dedicated to thoroughly evaluating and rating the performance of Aveanna Healthcare Holdings Inc (AVAH) in the stock market.The consensus estimate for the next quarter is $0.08, with high estimates of $0.11 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.48 and $0.39 for the fiscal current year, implying an average EPS of $0.44. EPS for the following year is $0.5, with 9.0 analysts recommending between $0.58 and $0.37.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $577.01M this quarter.It ranges from a high estimate of $589.71M to a low estimate of $566.8M. As of. The current estimate, Aveanna Healthcare Holdings Inc’s year-ago sales were $509.02MFor the next quarter, 8 analysts are estimating revenue of $584.58M. There is a high estimate of $599.53M for the next quarter, whereas the lowest estimate is $578.5M.
A total of 8 analysts have provided revenue estimates for AVAH’s current fiscal year. The highest revenue estimate was $2.32B, while the lowest revenue estimate was $2.3B, resulting in an average revenue estimate of $2.31B. In the same quarter a year ago, actual revenue was $2.02BBased on 8 analysts’ estimates, the company’s revenue will be $2.46B in the next fiscal year. The high estimate is $2.52B and the low estimate is $2.42B.
